Although most follicular-derived thyroid cancers are well differentiated and have an overall
excellent prognosis following treatment with surgery and radioiodine, management of …

Purpose Although most patients with differentiated thyroid carcinoma (DTC) have an
excellent prognosis, a subset will experience radioactive iodine refractory (RAI-R) disease …

The management of differentiated thyroid cancer (DTC) relies on the effectiveness of
radioiodine therapy (RIT), a cornerstone treatment that uses the ability of thyroid cells to …

Multifocal papillary thyroid carcinomas (PTCs) are common and the majority of the tumors
harbor mutual BRAF p. V600E mutation. This study aimed to investigate a contemporary …

It is well established that patients with the most differentiated thyroid cancers have a good
prognosis, whereas when the disease develops into radio-iodine refractory thyroid cancer …

Since the 1940s, 131-I radioiodine therapy (RIT) has been the primary treatment for
metastatic differentiated thyroid cancer (DTC). Approximately half of these patients respond …

Objective To investigate the feasibility and evaluate the safety and effectiveness of
Computed Tomography (CT) guided125I radioactive particle implantation for treating lymph …

Background Although differentiated thyroid cancer (DTC) is generally indolent, DTC with
progressive, persistent, or recurrent distant metastatic disease has a poor prognosis. 1 …

抄録 今回の甲状腺腫瘍診療ガイドライン改定において, 甲状腺分化癌に対する放射性ヨウ素 (RAI:
radioactive iodine) 内用療法では特に補助療法に焦点が当てられた. 国内外における RAI …

A29-y-old woman requiring total thyroidectomy with lymph node dissection for a stage pT3
(m) N1bMxR2 solid variant of papillary thyroid cancer had, near the left recurrent vagal …